Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003458.pub4Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 08 diciembre 2010see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Neuromuscular
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
RQ and RB were involved in the original review and agreed criteria for inclusion of studies and their methodological quality. RQ and MA were involved in assessing the two new studies included in the updated review. RQ completed the first and second updated drafts with agreement and approval from RB and MA. RQ completed this update with agreement and approval of AM and BS.
Sources of support
Internal sources
-
None, Not specified.
External sources
-
None, Not specified.
Declarations of interest
Two authors (RB and RQ) were involved in the conduct of a randomized cross‐over placebo controlled trial of vitamin B6, which did not demonstrate any overall benefit. One author (AM) was involved in the conduct of a randomized controlled trial of ramipril which did not demonstrate any significant benefit. One author (BS) was involved in an unblinded observational study of high fat diet which showed no benefit.
Acknowledgements
Rob Beynon was second author in the original review and first two updates.
We thank the Muscular Dystrophy Campaign of Great Britain and the Association for Glycogen Storage Diseases (AGSD). We dedicate this review to Nicholas Owston, who sadly died in 2003, in acknowledgement of his untiring support through the AGSD.
Editorial support from the Cochrane Neuromuscular Disease Group was funded by the TREAT NMD Network European Union Grant 036825.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Nov 12 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) | Review | Rosaline Quinlivan, Andrea Martinuzzi, Benedikt Schoser | |
| 2010 Dec 08 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) | Review | Rosaline Quinlivan, Andrea Martinuzzi, Benedikt Schoser | |
| 2008 Apr 23 | Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) | Review | Rosaline Quinlivan, Robert J Beynon, Andrea Martinuzzi | |
| 2004 Jul 19 | Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V) | Review | Rosaline Quinlivan, Robert J Beynon | |
| 2002 Jan 21 | Pharmacological and nutritional treatment for McArdle's disease (Glycogen storage disease type V) | Protocol | Ros Quinlivan, Robert J Beynon | |
Differences between protocol and review
In this update of the review, the most recent trials were assessed for risk of bias according to the new Cochrane risk of bias assessment method (Higgins 2008).
